Immunolocalization of corticotropin-releasing hormone (CRH) and its receptors (CRHR1 and CRHR2) in human endometrial carcinoma: CRHR1 as a potent prognostic factor.

Abstract

OBJECTIVE:

Corticotropin-releasing hormone (CRH), a major regulator of the stress response, regulates various biological functions through its interaction with CRH receptors 1 (CRHR1) and 2 (CRHR2). CRH, CRHR1, and CRHR2 have recently been reported in several types of carcinoma, but the significance of these proteins has remained largely unknown in human endometrial carcinoma.

MATERIALS AND METHODS:

A total of 87 endometrial carcinoma specimens were obtained from Japanese female patients who underwent surgical treatment, fixed in 10% formalin, and embedded in paraffin wax. Immunohistochemistry for CRH, CRHR1, and CRHR2 was performed, and clinical data were obtained from the medical records.

RESULTS:

Immunopositivity of CRH, CRHR1, and CRHR2 in the specimens was 26%, 15%, and 10%, respectively. Univariate analysis revealed that immunohistochemical CRH status was positively associated with CRHR1 and CRHR2 status and that CRHR1 status was significantly associated with the risk of recurrence and poorer clinical outcome, whereas CRHR2 status was marginally associated with better prognosis for overall survival. Multivariate analysis demonstrated CRHR1 status as an independent prognostic factor for both disease-free and overall survival.

CONCLUSIONS:

These results suggest that intratumoral CRH-CRHR1 signaling plays an important role in the progression of endometrial carcinoma and that CRHR1 is a potent prognostic factor in patients with this disease.

• Authors: Naoko Sato, Kiyoshi Takagi, Takashi Suzuki, Yasuhiro Miki, Sota Tanaka, Satoru Nagase, Hitoshi Warita, Shin Fukudo, Fumiko Sato, Hironobu Sasano, Kiyoshi Ito
• Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (Int J Gynecol Cancer) Vol. 24 Issue 9 Pg. 1549-57 (Nov 2014) ISSN: 1525-1438 [Electronic] England
• PMID: 25254562 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Biomarkers, Tumor
• CRF receptor type 2
• Receptors, Corticotropin-Releasing Hormone
• CRF receptor type 1
• Corticotropin-Releasing Hormone

Topics

• Adenocarcinoma (metabolism, mortality, secondary, surgery)
• Adult
• Aged
• Biomarkers, Tumor (metabolism)
• Corticotropin-Releasing Hormone (metabolism)
• Endometrial Neoplasms (metabolism, mortality, pathology, surgery)
• Female
• Follow-Up Studies
• Humans
• Immunoenzyme Techniques
• Lymphatic Metastasis
• Middle Aged
• Neoplasm Grading
• Neoplasm Invasiveness
• Neoplasm Recurrence, Local (metabolism, mortality, pathology, surgery)
• Prognosis
• Receptors, Corticotropin-Releasing Hormone (metabolism)
• Survival Rate